John Overdeck’s Orphazyme A/S ORPH Stock Holding History

John Overdeck’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-141,117	Closed	-$340K	–	4780
2021 Q4	$340K	Sell	141,117 -98,820	-41%	-$349K	﹤0.01%	3558
2021 Q3	$986K	Buy	+239,937	New	+$1.23M	﹤0.01%	2635

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

John Overdeck's ORPH Position: Q1 2022 in Review

John Overdeck sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 141,117 shares — an estimated $340K sold.

John Overdeck first reported a position in ORPH in Q3 2021 and held it in 2 quarters. The position peaked at $986K in Q3 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

John Overdeck reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
John Overdeck sold 141,117 Orphazyme A/S shares in Q1 2022, an estimated $340K.
John Overdeck first reported a position in Orphazyme A/S in Q3 2021 and held it in 2 quarters.
John Overdeck's Orphazyme A/S position peaked at $986K in Q3 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.